Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the combination of focused ultrasound ablation with PD-1 antibody blockade in advanced solid tumors has been termin…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment
An observational clinical study evaluating stereotactic radiotherapy for advanced non-small cell lung cancer in patients with stable disease…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer [Phase 2]
This Phase 2 trial studied the combination of ramucirumab and pembrolizumab in EGFR-mutant recurrent or metastatic non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors [Phase 1]
A Phase 1 trial of INCB106385, alone or with immunotherapy, in advanced solid tumors has completed. The study includes multiple indications …
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial of intratumoral gene-mediated cytotoxic immunotherapy for resectable non-small cell lung cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 [Phase 1]
Phase 1 clinical trial evaluating XMT-2056 in HER2-expressing advanced or recurrent solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors [Phase 2]
Telix's phase 2 trial of the CAIX-targeting PET tracer 89Zr-girentuximab in CAIX-positive solid tumors was terminated.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Personalized DC Vaccines in Non Small Cell Lung Cancer [Phase 1]
Phase 1 trial update on a personalized dendritic cell vaccine for non-small cell lung cancer; the study status is ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC [Phase 2]
A Phase 2 trial evaluating radiation therapy followed by tislelizumab and anlotinib as adjuvant or neoadjuvant therapy for Stage II-IIIA non…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT [Phase 2]
Phase 2 clinical trial evaluating radiotherapy plus anlotinib for locally advanced non-small cell lung cancer intolerant to concurrent chemo…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
This clinical trial is evaluating multiple omics sequencing technologies to predict treatment efficacy in non-small cell lung cancer and to …
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Study of Atezolizumab in Advanced Non-oncogene-addicted NSCLC With PD-L1 ≥50%, Including Longitudinal c-FLIP Assessment in Monocytic MDSCs.
A study evaluating atezolizumab in PD-L1 high advanced non-small cell lung cancer with correlative c-FLIP analysis in monocytic myeloid-deri…
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir) [Phase 1]
A Phase 1 clinical trial evaluating TG6050 for metastatic non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS other · 2025-07-09Clinical Trial Update: Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors [Phase 1]
A Phase I clinical trial of BC008-1A injection for advanced solid tumors is currently recruiting. The study includes patients with advanced …
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Lapatinib Plus Trametinib in KRAS Mutant NSCLC [Phase 1, Phase 2]
Phase 1/2 trial results assess the combination of lapatinib and trametinib in KRAS-mutant cancers, including colorectal cancer and non-small…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Efficacy of Argon-Helium Cryoablation Plus PD-1 Inhibitors in NSCLC [NA]
A completed clinical trial evaluated the efficacy of combining Argon-Helium Cryoablation with PD-1 inhibitors in non-small cell lung cancer.…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLC [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluates the combination of dacomitinib and PD-0325901 in advanced KRAS-mutant non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial (CHIO3) is evaluating chemotherapy combined with an immune checkpoint inhibitor for operable stage IIIA/IIIB non-small cell …
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: A Study of Effectiveness and Safety of the First-Line Nivolumab Plus Ipilimumab With or Without Chemotherapy for Advanced/Recurrent Non-Small Cell Lung Cancer in Japan
A clinical trial in Japan is evaluating the effectiveness and safety of first-line nivolumab plus ipilimumab, with or without chemotherapy, …
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4
A clinical trial update indicates the SNP study ICORG 08-40, Version 4, sponsored by Cancer Trials Ireland, for colorectal cancer and non-sm…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy
A clinical trial update examining tumor-associated neutrophils as a biomarker of chemo-immunotherapy response in locally advanced non-small …
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors [Phase 1]
This Phase 1 trial assesses Autogene Cevumeran (RO7198457) as a single agent and in combination with atezolizumab across multiple locally ad…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy
This clinical trial update discusses using geriatric assessment to guide treatment decisions for elderly patients with locally advanced non-…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLC [Phase 2]
A Phase 2 clinical trial evaluating JS207 in combination with chemotherapy as first-line treatment for advanced non-small cell lung cancer, …
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Metabolic Response to Food in Lung Cancer
This clinical trial investigates how metabolic response to food occurs in Non-Small Cell Lung Cancer. The study is currently active but not …